Mendus AB (publ)
STO:IMMU

Watchlist Manager
Mendus AB (publ) Logo
Mendus AB (publ)
STO:IMMU
Watchlist
Price: 5.08 SEK 1.91% Market Closed
Market Cap: 309.6m SEK

Wall Street
Price Targets

IMMU Price Targets Summary
Mendus AB (publ)

Wall Street analysts forecast IMMU stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMMU is 17.34 SEK with a low forecast of 17.17 SEK and a high forecast of 17.85 SEK.

Lowest
Price Target
17.17 SEK
238% Upside
Average
Price Target
17.34 SEK
241% Upside
Highest
Price Target
17.85 SEK
251% Upside
Mendus AB (publ) Competitors:
Price Targets
KRYS
Krystal Biotech Inc
4% Downside
2171
CARsgen Therapeutics Holdings Ltd
59% Upside
SVRA
Savara Inc
64% Upside
MIRM
Mirum Pharmaceuticals Inc
34% Upside
CAPR
Capricor Therapeutics Inc
47% Upside
4BB
4Basebio PLC
167% Upside
7774
Japan Tissue Engineering Co Ltd
158% Upside
LXRX
Lexicon Pharmaceuticals Inc
145% Upside

Revenue
Forecast

Revenue Estimate
Mendus AB (publ)

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Mendus AB (publ)

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Mendus AB (publ)

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMMU's stock price target?
Price Target
17.34 SEK

According to Wall Street analysts, the average 1-year price target for IMMU is 17.34 SEK with a low forecast of 17.17 SEK and a high forecast of 17.85 SEK.

Back to Top